Influence of nanoencapsulation on human skin transport of flufenamic acid

Skin Pharmacology and Physiology

Volumn 19, Issue 4, 2006, Pages 190-197

  Luengo, J ^a,b   Weiss, B ^b   Schneider, M ^b   Ehlers, A ^c   Stracke, F ^c   Konig K ^c   Kostka, K H ^d   Lehr, C M ^b   Schaefer, U F ^b,d  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b SAARLAND UNIVERSITY   (Germany)

^c FRAUNHOFER INSTITUTE FOR BIOMEDICAL ENGINEERING   (Germany)

^d Caritaskrankenhaus ^*  (Germany)

Author keywords

Drug delivery system; Drug penetration; Drug permeation; Multiphoton fluorescence microscopy; Poly(lactide co glycolide) nanoparticles

Indexed keywords

FLUFENAMIC ACID; POLYGLACTIN;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DERMATOGLYPHICS; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG PENETRATION; DRUG TRANSPORT; ENCAPSULATION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MODEL; MULTIPHOTON MICROSCOPY; NANOENCAPSULATION; PRIORITY JOURNAL; SKIN FUNCTION; SKIN PENETRATION; SKIN SURFACE; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION;

ADMINISTRATION, CUTANEOUS; BIOLOGICAL TRANSPORT; DERMIS; EPIDERMIS; FEMALE; FLUFENAMIC ACID; HUMANS; LACTIC ACID; NANOPARTICLES; POLYGLYCOLIC ACID; POLYMERS; SKIN ABSORPTION;

EID: 33746329873     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093114     Document Type: Article

References (26)

1. US Environmental Protection Agency: Dermal exposure assessment: principles and applications. Washington, United States Environmental Protection Agency, Office of Health and Environmental Assessment, 1992.
2. Hadgraft J: Skin deep. Eur J Pharm Biopharm 2004;58:291-299.
3. Hadgraft J: Skin, the final frontier. Int J Pharm 2001;224:1-18.
4. Walters KA, Roberts MS: The structure and function of the skin; in Walters KA (ed): Dermatological and Transdermal Formulations. Drugs and the Pharmaceutical Sciences. New York, Dekker, 2002, vol 119, pp 1-39.
5. Cleary GW: Transdermal and transdermal-like delivery system opportunities: today and the future. Drug Deliv Technol 2003;3:35-40.
6. Barry BW: Dermatological Formulations. Percutaneous Absorption: Drugs and the Pharmaceutical Sciences. New York, Dekker, 1983, vol 18.
7. Williams AC, Barry BW: Penetration enhancers. Adv Drug Deliv Rev 2004;56:603-618.
8. Wagner H, Kostka K-H, Adelhardt W, Schaefer UF: Effects of various vehicles on the penetration of flufenamic acid into human skin. Eur J Pharm Biopharm 2004;58:121-129.
9. Kohli AK, Alpar HO: Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm 2004;275:13-17.
10. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U: Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 2004;123:168-176.
11. Lademann J, Schaefer H, Otberg N, Blume-Peytavi U, Sterry W: Penetration von Mikropartikeln in die menschliche Haut. Hautarzt 2004;55:1117-1119.
12. Jenning V, Gysler A, Schafer-KortingM, Gohla SH: Vitamin A-loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000;49:211-218.
13. Jenning V, Schafer-Korting M, Gohla S: Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 2000;66:115-126.
14. Santos Maia C, Mehnert W, Schafer-Korting M: Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm 2000;196:165-167.
15. Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H: Skin penetration and distribution of polymeric nanoparticles. J Control Release 2004;99:53-62.
16. Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H: Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004;21:1818-1825.
17. Brannon-Peppas L: Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm 1995;116:1-9.
18. Hans ML, Lowman AM: Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002;6:319-327.
19. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE: Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1-20.
20. Ravi Kumar MNV, Sameti M, Kneuer C, Lamprecht A, Lehr C-M: Polymeric nanoparticles for drug and gene delivery; in Nalwa HS (ed): Encyclopedia of Nanoscience and Nanotechnology. American Scientific Publishers, 2003, vol 10, pp 1-19.
21. Wagner H, Kostka K-H, Lehr C-M, Schaefer UF: Drug distribut ion in human skin using two different in vitro test systems: comparison with in vivo data. Pharm Res 2000;17:1475-1481.
22. Dick IP, Scott RC: Pig ear skin as an in vitro model for human skin permeability. J Pharm Pharmacol 1992;44:640-645.
23. König K, Riemann I: High-resolution multiphoton tomography of human skin with subcellular spatial resolution and picosecond time resolution. J Biomed Opt 2003;8:432-439.
24. Bronaugh RL, Stewart RF, Morton S: Methods of in vitro percutaneous absorption studies VII: use of excised human skill. J Pharm Sci 1986;75:1094-1097.
25. Abignente E, De Caprariis P: Flufenamic Acid. Analytical Profiles of Drug Substances. In Florey K (ed), Academic Press, 1982, vol 11, pp 313-346.
26. Fu K, Pack DW, Klibanov AM, Langer R: Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res 2000;17:100-106.